Cargando…

Indian Regulatory Update-2 during the COVID-19 pandemic

Detalles Bibliográficos
Autor principal:	Bhave, Amita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2020
Materias:	Regulatory Update
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819367/ https://www.ncbi.nlm.nih.gov/pubmed/33489838 http://dx.doi.org/10.4103/picr.picr_318_20

Ejemplares similares

Indian regulatory update during the COVID-19 pandemic
por: Bhave, Amita Chandan
Publicado: (2020)

Indian Regulatory Update: January-December 2017
por: Bhave, Amita
Publicado: (2018)

Indian Regulatory Update: January – March 2018
por: Bhave, Amita
Publicado: (2018)

Indian regulatory update April–October 2018
por: Bhave, Amita, et al.
Publicado: (2019)

Indian regulatory update 2013
por: Suvarnapathaki, Kedar
Publicado: (2013)

Indian Regulatory Update: Jan-May 2014
por: Suvarnapathaki, Kedar
Publicado: (2014)

Indian Regulatory Update: June-August 2014
por: Suvarnapathaki, Kedar
Publicado: (2014)

Indian Regulatory Update: September-November 2013
por: Suvarnapathaki, Kedar
Publicado: (2014)

Indian Regulatory Update: January-March 2015
por: Suvarnapathaki, Kedar
Publicado: (2015)

Regulatory Considerations for Biosimilars
por: Nellore, Ranjani
Publicado: (2010)

Regulatory requirements for marketing fixed dose combinations
por: Jayasheel, B. G.
Publicado: (2010)

Drug Lag and Key Regulatory Barriers in the Emerging Markets
por: Wileman, Harriet, et al.
Publicado: (2010)

UpdatesMental support for health care professionals essential during the COVID-19 pandemic
por: de Vroege, Lars, et al.
Publicado: (2020)

Key points of technical review for the registration of SARS-CoV-2 antigen/antibody tests
por: Li, Hongran, et al.
Publicado: (2021)

China's NMPA perspective on the clinical performance of SARS-CoV-2 antigen test reagents
por: Lv, Yunfeng, et al.
Publicado: (2022)

Key points of technical review for the registration of SARS-CoV-2 nucleic acid tests in China
por: Li, Hongran, et al.
Publicado: (2021)

China NMPA perspective on clinical evaluation of SARS-CoV-2 antibody test reagents in the process of emergency approval
por: Lv, Yunfeng, et al.
Publicado: (2020)

Conducting a phase III clinical trial in children during the COVID- 19 pandemic: Experience and lessons learnt from a clinical research facility of Nepal
por: Chapagain, Ram Hari, et al.
Publicado: (2023)

Regulations and guidelines governing stem cell based products: Clinical considerations
por: George, Bobby
Publicado: (2011)

Registration of Medical Devices
por: George, Bobby
Publicado: (2010)

Implications of ICH-E5: Assessment of drug's sensitivity to ethnic factors and necessity of a bridging study for global drug development
por: Gupta, Sandeep Kumar
Publicado: (2011)

Injury and death in clinical trials and compensation: Rule 122 DAB
por: Ghooi, Ravindra. B.
Publicado: (2013)

4349 Survey of Regulatory Reforms to Address Comprehension of Clinical Trial Results
por: Kirkland, Matthieu, et al.
Publicado: (2020)

Update to Perinatal-Neonatal Management of COVID-19 Guidelines
por: Sivanandan, Sindhu, et al.
Publicado: (2021)

Advancing a Framework for Regulatory Use of Real-World Evidence: When Real Is Reliable
por: Dreyer, Nancy A.
Publicado: (2018)

Translating New Science Into the Drug Review Process: The US FDA’s Division of Applied Regulatory Science
por: Rouse, Rodney, et al.
Publicado: (2017)

81007 Training Biomedical Engineers in Regulatory Science: Critical Role of Experts from Industry and FDA
por: Lottes, Aaron E., et al.
Publicado: (2021)

Regulatory Issues: PMDA – Review of Sakigake Designation Products: Oncolytic Virus Therapy with Delytact Injection (Teserpaturev) for Malignant Glioma
por: Maruyama, Yoshiaki, et al.
Publicado: (2023)

Navigating migraine care through the COVID-19 pandemic: an update
por: Angus-Leppan, Heather, et al.
Publicado: (2021)

Standardisation of defined approaches for skin sensitisation testing to support regulatory use and international adoption: position of the International Cooperation on Alternative Test Methods
por: Casati, S., et al.
Publicado: (2017)

The collective voice of early phase COVID-19 vaccine trial participants: Insights for improving confidence in novel vaccines
por: Thomas, Tonia M., et al.
Publicado: (2023)

Results of mental support for health care professionals and mental care during the COVID-19 pandemic
por: de Vroege, Lars, et al.
Publicado: (2021)

396 Quantitative Analysis of FDA Warning Letters Related to the Use of Social Media Sites in Product Misbranding for the Treatment, Prevention, or Diagnosis of COVID-19
por: Ajaj, Mahmoud, et al.
Publicado: (2023)

Neurological update: COVID-19
por: Ren, A. L., et al.
Publicado: (2021)

Testing an early online intervention for the treatment of disturbed sleep during the COVID-19 pandemic in self-reported good and poor sleepers (Sleep COVID-19): study protocol for a randomised controlled trial
por: Sawdon, Olivia L., et al.
Publicado: (2021)

Updates of incretin‐related drugs for the treatment of type 2 diabetes
por: Araki, Hirotaka, et al.
Publicado: (2022)

Update in HIV Care
por: Berkenblit, Gail, et al.
Publicado: (2007)

Update in Women’s Health
por: Walsh, Judith M. E., et al.
Publicado: (2009)

Oral nicotine pouches with an aftertaste? Part 2: in vitro toxicity in human gingival fibroblasts
por: Rinaldi, Selina, et al.
Publicado: (2023)

Updates on dyslipidemia in patients with diabetes
por: Ide, Shintaro, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g0qhv49jh1c05ksc7ubepabb4n